Initiator Pharma A/S Initiator Pharma A/S

Initiator Pharma A/S

INIT

Rank in Stocks #27246
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to... Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.23069763
Last synced: 2026-11-12
Market Cap
$15.79M
Change (1 day)
-8.56%
Change (1 year)
-26.10%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
Stock split history for Initiator Pharma A/S (INIT)
Initiator Pharma A/S stock (symbol: INIT) underwent a total of 1 stock splits.
The most recent stock split occurred on Oct 25, 2021.
One INIT share bought prior to Oct 25, 2021 would equal to 1.074 INIT shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2021-10-25 537:500 x1.074 x1.074
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
0 -
US
1 x2
US
0 -
US
1 x3
AU
1 x100
BE

Questions about Initiator Pharma A/S's stock splits

How many times has Initiator Pharma A/S split its stock?

Initiator Pharma A/S (INIT) has split its stock once, on Oct 25, 2021.

How many shares would one Initiator Pharma A/S share bought before Oct 25, 2021 be today?

After all its stock splits, one share bought before Oct 25, 2021 would be 1.07 shares today.